pyrazines has been researched along with AIDS-Associated Lymphoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonavida, B; Huerta-Yepez, S; Jazirehi, AR; Martinez-Maza, O; Martinez-Paniagua, M; Umezawa, K; Vega, MI | 1 |
| Bose, P; Gandhi, D; Ghabach, B; Ozer, H; Thompson, C | 1 |
| Carbone, A; Gloghini, A; Spina, M; Tirelli, U | 1 |
| Boulanger, E; Meignin, V; Oksenhendler, E | 1 |
1 review(s) available for pyrazines and AIDS-Associated Lymphoma
| Article | Year |
|---|---|
Therapeutic options for HIV-associated lymphomas.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Boronic Acids; Bortezomib; Epstein-Barr Virus Infections; HIV Infections; Humans; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Pyrazines; Rituximab; Treatment Outcome | 2010 |
3 other study(ies) available for pyrazines and AIDS-Associated Lymphoma
| Article | Year |
|---|---|
The NF-kappaB inhibitors (bortezomib and DHMEQ) sensitise rituximab-resistant AIDS-B-non-Hodgkin lymphoma to apoptosis by various chemotherapeutic drugs.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Apoptosis; Benzamides; Boronic Acids; Bortezomib; Cell Line, Tumor; Cyclohexanones; Drug Resistance, Neoplasm; Humans; Lymphoma, AIDS-Related; Lymphoma, B-Cell; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Rituximab | 2008 |
AIDS-related plasmablastic lymphoma with dramatic, early response to bortezomib.
Topics: Adult; Boronic Acids; Bortezomib; Humans; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Immunoblastic; Male; Pyrazines; Remission Induction; Shock, Septic | 2009 |
Bortezomib (PS-341) in patients with human herpesvirus 8-associated primary effusion lymphoma.
Topics: Adult; Antineoplastic Agents; Boronic Acids; Bortezomib; Female; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Lymphoma, AIDS-Related; Lymphoma, Primary Effusion; Male; Middle Aged; Pyrazines | 2008 |